Early molecular response and female sex strongly predict stable undetectable BCR-ABL1 , the criteria for imatinib discontinuation in patients with CML
Branford, Susan, Yeung, David T, Ross, David M, Prime, Jodi A, Field, Chani R, Altamura, Haley K, Yeoman, Alexandra L, Georgievski, Jasmina, Jamison, Bronte A, Phillis, Stuart, Sullivan, Brad, Briggs,Volume:
121
Year:
2013
Language:
english
DOI:
10.1182/blood-2012-10-462291.The
File:
PDF, 1.04 MB
english, 2013